Ocular Hypertension Completed Phase 3 Trials for Latanoprost (DB00654)

Also known as: Intraocular pressure raised / Ocular Hypertension (OHT) / Hypertension Ocular / Hypertension, Ocular / Intraocular pressure high / Intraocular hypertension / Ocular Hypertension (OH) / Elevated intraoccular pressure / Intraocular pressure increased / IOP increased / Raised IOP / Ocular tension increased / Tension ocular increased / Pressure intraocular increased / Increased intraocular pressure

IndicationStatusPhase
DBCOND0074237 (Ocular Hypertension)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02558400Double-masked Study of PG324 Ophthalmic Solution in Patients With Glaucoma or Ocular HypertensionTreatment
NCT02674854Double-masked Study of PG324 Ophthalmic Solution in Patients With Open-angle Glaucoma or Ocular HypertensionTreatment
NCT00856622A Study Demonstrating The Effect Of Latanoprost In Combination With Timolol, Latanoprost Alone And Timolol Alone On Eye Pressure In Open Angle Glaucoma Or Ocular Hypertension In PatientsTreatment
NCT02059278Safety and Efficacy of T-2345 Compared to Xalatan in Subjects With Primary Open Angle Glaucoma or Ocular HypertensionTreatment
NCT02278614Efficacy and Safety Assessment of T2347 Versus Xalacom® in Ocular Hypertensive or Glaucomatous PatientsTreatment
NCT00800267A Study of Glaucoma or Ocular Hypertension in Patients Within the United StatesTreatment
NCT02105272Efficacy and Safety Study of OPC-1085EL Ophthalmic Solution in Subjects With Glaucoma or Ocular HypertensionTreatment
NCT00892762Travoprost APS Versus Xalatan® in Patient Reported Outcomes and Ocular Surface HealthTreatment
NCT00761319Phase III Clinical Trial of TRAVATAN Z in Ocular Surface HealthTreatment
NCT00751049A Study of Open Angle Glaucoma or Ocular Hypertension in Patients Within the United KingdomTreatment
NCT00751127A 6 Month Study Comparing Latanoprost With Timolol in Patients With Open Angle Glaucoma or Ocular HypertensionTreatment
NCT00751062A Study of Open Angle Glaucoma or Ocular Hypertension in Patients Within ScandinaviaTreatment
NCT00051181A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Chronic Angle-Closure GlaucomaTreatment
NCT00051142A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT)Treatment
NCT00690794Travatan Z in Ocular Surface Health in Patients With Open-Angle Glaucoma or Ocular HypertensionTreatment
NCT00311389A 12-Month Study to Evaluate the Efficacy and Safety of Once-Daily Instillation of Combination Glaucoma Therapy in Patients With Open-Angle Glaucoma or Ocular HypertensionTreatment
NCT00293787A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular HypertensionTreatment
NCT00293800A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular HypertensionTreatment
NCT00277498A 12-week, Randomized, Double-masked, Parallel Group Comparison of Evening Dosing With Xalacom in Subjects With GlaucomaTreatment
NCT00219596Xalacom And Combination Of Unfixed Latanoprost And Timolol In Subjects With Open-Angle Glaucoma Or Ocular HypertensionTreatment
NCT00230763Determination Of Predictive Factors Allowing To An Additional 10% Reduction Of Intra-Ocular PressureTreatment
NCT00150267A 5-Year Postmarketing Safety Study Of Xalcom In Patients With Open Angle Glaucoma Or Ocular HypertensionTreatment
NCT00159653A 12-Week, Randomized, Double-Masked, Parallel Group Comparison Of Evening Dosing With Xalacom In Subjects With GlaucomaTreatment
NCT00383019A Study Comparing Xalacom And Xalatan In Patients With Primary Open Angle Glaucoma (POAG) Or Ocular Hypertension (OH).Treatment